Gantenerumab does not slow clinical decline in early Alzheimer’s disease
Nov 16, 2023
Two trials show a lower amyloid plaque burden with gantenerumab versus placebo at 116 weeks.
Higher, lower HDL cholesterol linked to increased risk for dementia
Oct 04, 2023
An increased risk for Alzheimer’s disease and related dementia was seen in association with higher and lower versus middle quintile of HDL-C.
Vasomotor symptoms linked to increased risk for Alzheimer’s disease
Sep 27, 2023
Objectively assessed VMS (so-called hot flashes), including sleep VMS, are associated with significantly lower amyloid-β42/40.
Physical jobs tied to higher risk for later cognitive impairment
Sep 22, 2023
The analysis included occupational trajectories from ages 33 to 65 years.
Moderna COVID-19 vaccine tied to lower adverse event risk in older adults
Aug 11, 2023
The mRNA-1273 vaccine also was tied to greater protection against COVID-19 in older adults.
Patients at memory clinic more likely to live in advantaged areas
Aug 03, 2023
Lower percentage of patients at clinic self-identified as Black compared with average percentage living in catchment area
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Nirmatrelvir cuts risk for post-COVID-19 condition
Mar 27, 2023
The findings were seen regardless of vaccination status and history of prior infection.
Risk for dementia increased with low bone mineral density
Mar 24, 2023
Participants with lower bone mineral density at the femoral neck were more likely to develop all-cause dementia and Alzheimer’s disease during follow-up,